This protocol covers the treatment of seborrheic dermatitis localised to the scalp in adult patients, with a focus on reducing the key signs and symptoms of the condition.
Adult patient presenting with seborrheic dermatitis of the scalp. The approach is tailored to scalp localisation and the adult age group.
Management relies on topical scalp therapy. Agents from antifungal, anti-inflammatory, and keratolytic/humectant classes are strongly recommended for adults with scalp involvement. The specific agents, schedules, and sequencing are detailed in the full protocol.
Treatment goals: Reduction of scalp erythema, scaling, and pruritus.
In adults, the use of topical agents with antifungal (ketoconazole, ciclopirox, miconazole), antiinflammatory (betamethasone valerate, clobetasol propionate) or keratolytic/humectant (propylene glycol) properties is strongly recommended (Table 1).
The recommended frequency of use of 2% KTZ shampoo is twice weekly over 4 weeks.
The use of topical potent (betamethasone valerate) to super potent (clobetasol propionate) corticosteroids (Level A) (class III–IV according to Anatomical Therapeutic Chemical [ATC] classification) with anti-inflammatory, immunosuppressive and antiproliferative actions allows to achieve quick control of erythema, scaling and pruritus.
View source ↗